You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Honduras Drug Patents


✉ Email this page to a colleague

« Back to Dashboard


Drug Patents in Honduras and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent NumberEstimated ExpirationEquivalent US PatentUS Expiry DateGeneric NameUS ApplicantUS Tradename
1998000071 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate Viiv Hlthcare ZIAGEN
1999000161 ⤷  Try for Free 5047407 2010-05-17 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
1998000071 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
1999000161 ⤷  Try for Free 7119202 2009-08-08 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
1999000161 ⤷  Try for Free 5047407 2010-05-17 abacavir sulfate; lamivudine; zidovudine Viiv Hlthcare TRIZIVIR
1998000071 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine; zidovudine Viiv Hlthcare TRIZIVIR
1999000161 ⤷  Try for Free 7119202 2009-08-08 abacavir sulfate; lamivudine; zidovudine Viiv Hlthcare TRIZIVIR
>Patent Number>Estimated Expiration>Equivalent US Patent>US Expiry Date>Generic Name>US Applicant>US Tradename
Showing 1 to 7 of 7 entries

Protecting Biopharmaceutical Patents in Honduras: Key Insights

Introduction to Intellectual Property in Honduras

When it comes to protecting biopharmaceutical patents in Honduras, it is crucial to understand the country's intellectual property (IP) laws and the specific mechanisms in place for patent protection. Honduras's IP protection regime is managed by the General Directorate of Intellectual Property (DIGEPIH), which is part of the Honduran Property Institute (IP)[1][2].

Registration and Protection

First-to-File Principle

In Honduras, patents and trademarks are granted on a first-to-file basis. This means that the first entity to file for a patent or trademark will be granted the rights, regardless of who was the first to use the mark or invent the product. Therefore, it is essential for companies to register their patents and trademarks with DIGEPIH before introducing their products or services to the Honduran market[1][2].

Term of Protection

  • Patents are protected for 20 years from the filing date.
  • Trademarks are valid for up to 10 years from the registration date and can be renewed.
  • Data protection is provided for five years[1][2].

Patentability of Biopharmaceutical Inventions

Compliance with International Agreements

Honduras is a party to several international agreements, including the Paris Convention for the Protection of Industrial Property and the Patent Cooperation Treaty (PCT). This ensures that Honduras's IP protection regime conforms to international standards, including those related to biopharmaceutical inventions[5].

Specific Considerations for Biopharmaceuticals

Biopharmaceutical inventions, such as those involving genetic therapies, must comply with specific regulations. For instance, methods of medical treatment are often excluded from patentability in many jurisdictions. However, Honduras does offer process patent protection, which can be relevant for biopharmaceutical processes[1][4].

Scope of Claims

Enablement and Written Description

The scope of patent claims, particularly in the biopharmaceutical sector, can be complex. The enablement and written description doctrines, similar to those in the U.S., play a critical role. In Honduras, the patent application must enable the public to make and use the invention, and it must include a written description of the invention. However, the specific application of these doctrines can vary, and it is important to ensure that the patent claims are sufficiently detailed to meet these requirements[3].

Extension of Patent Term

Honduras allows for the extension of the patent term under certain conditions, such as delays in the registration process or in obtaining regulatory approval for pharmaceutical products. This can be particularly relevant for biopharmaceutical patents, which often involve lengthy regulatory approval processes[5].

Enforceability of Patents

Legal Framework

Honduras's IP protection regime includes strong legal frameworks to enforce patents. The CAFTA-DR (Central American Free Trade Agreement - Dominican Republic) obligations provide for the criminalization of end-user piracy and the seizure, forfeiture, and destruction of counterfeit and pirated goods. Prosecutors can also file IP cases ex-officio, without requiring the affected company to file a criminal complaint[1][2].

Statutory and Actual Damages

Under CAFTA-DR, both statutory and actual damages can be awarded for copyright and trademark infringement. This ensures that monetary damages can be awarded even when it is difficult to assign a monetary value to the violation[1][2].

Challenges and Best Practices

Local Counsel and Advisors

Given the complexities of Honduran IP law, it is advisable for companies to seek advice from local attorneys or IP consultants who are experts in Honduran law. Delaying the enforcement of IP rights can result in erosion or abrogation of those rights[2].

Monitoring and Contesting Bad Faith Filings

There are numerous cases of bad faith filings of established trademarks in Honduras. Companies must be vigilant and contest such filings in court to protect their legitimate IP rights[1][2].

International Cooperation and Resources

WIPO and LATIPAT

Honduras is part of the World Intellectual Property Organization (WIPO) and the regional IP information platform LATIPAT. These resources provide valuable information and tools for navigating the IP landscape in Honduras[5].

Key Takeaways

  • Registration: Patents and trademarks must be registered with DIGEPIH on a first-to-file basis.
  • Protection Term: Patents are protected for 20 years, trademarks for 10 years, and data for five years.
  • International Compliance: Honduras's IP regime conforms to WTO norms and international agreements.
  • Scope of Claims: Ensure compliance with enablement and written description doctrines.
  • Enforceability: Strong legal frameworks, including CAFTA-DR obligations, support patent enforcement.
  • Local Expertise: Seek local counsel to navigate Honduran IP laws effectively.

FAQs

Q: What is the term of protection for patents in Honduras?

A: Patents are protected for 20 years from the filing date.

Q: How are trademarks protected in Honduras?

A: Trademarks are valid for up to 10 years from the registration date and can be renewed. They are granted on a first-to-file basis.

Q: Does Honduras offer any extension for the patent term?

A: Yes, the patent term can be extended in cases of delays in the registration process or in obtaining regulatory approval for pharmaceutical products.

Q: What international agreements is Honduras a part of regarding IP protection?

A: Honduras is a party to the Paris Convention, the Patent Cooperation Treaty (PCT), and the Budapest Treaty, among others.

Q: How can companies enforce their IP rights in Honduras?

A: Companies can enforce their IP rights through the legal system, with support from CAFTA-DR obligations, and by seeking advice from local attorneys or IP consultants.

Sources

  1. U.S. Department of Commerce. Honduras - Protecting Intellectual Property, January 25, 2024.
  2. U.S. Department of Commerce. Honduras - Trade Financing, January 25, 2024.
  3. Falati, S. Eviscerating Patent Scope, 21 UIC Rev. Intell. Prop. L. 121 (2022).
  4. Abinader and Contreras. The Patentability of Genetic Therapies, Utah Law Digital Commons, May 15, 2019.
  5. WIPO. Honduras - HN Jurisdiction - General Information Online Patent Register.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.